• Regulus Therapeutics (NASDAQ:RGLS) Given "Buy" Rating at Canaccord Genuity Group

    Source: Buzz FX / 18 Mar 2025 10:56:16   America/Chicago


    Regulus Therapeutics (NASDAQ:RGLS) Given "Buy" Rating at Canaccord Genuity Group Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Regulus Therapeutics ( NASDAQ:RGLS - Get Free Report ) 's stock had its "buy" r
    Read more...
Share on,